2014 Report on Local Anaesthesia in the GCC Region
DUBLIN, January 27, 2014 /PRNewswire/ –
Research and Markets (
http://www.researchandmarkets.com/research/pgsmp4/market_for_local) has announced the
addition of the “2014 Report on Local Anaesthesia in the GCC Region”
[http://www.researchandmarkets.com/research/pgsmp4/market_for_local ] report to their
Local anesthesia (LA) is a condition when sensation within a specific body part is
inhibited, whereas general anesthesia results in loss of consciousness and sensation.
This report focuses on the market for local anaesthetic products in the GCC region.
The market is strictly limited to application in human beings and comprises of products
administered through injectables and topicals. Local anaesthetic products find
applications in vast range of medical surgeries with some popular ones being dentistry,
child birth, circumcision etc.
Sharp rise in population within the GCC region coupled with rise in per capita income
has resulted in increased incidence of surgeries that involves usage of LA. In 2012,
market for LA drugs in GCC was valued at USD 14.2 Mn. Saudi Arabia and UAE were the main
markets in region contributing to more than 75% of demand.
At present, large part of this demand is catered by MNCs which import these drugs from
their manufacturing facilities in EU. Domestic production is limited to few regional
players in KSA and Kuwait. Going forward, demand for LA is projected to remain strong in
the region with Qatar and UAE showing promising growth.
Expanding health infrastructure, higher health care spend and increasing disease
incidences indicates the need and potential for LA drugs in the region. A detailed
analysis of end use growth trends and LA usage trend across each end use categories have
been presented to identify drivers and constraints end use wise.
In addition to key supplier data of LA in GCC and detailing on the market structure,
the authors have also studied the customer requirements and key purchase criteria and
buying process adopted by various end users. This report provides practical insights and
anecdotes of practices adopted by various end users. The authors believe these granular
details and insights along with forecast will help all the stakeholders – be it the LA
manufacturer, distributor and end users such as doctors, clinics and hospitals to take
- Articaine - Bupivacaine - Lidocaine - Mepivacaine - Prilocaine
Key Topics Covered:
2. Glossary of terms
3. GCC Market Analysis
4. Bahrain LA Market Analysis
5. Kingdom of Saudi Arabia (KSA) LA Market Analysis
6. Kuwait LA Market Analysis
7. Oman LA Market Analysis
8. Qatar LA Market Analysis
9. UAE LA Market Analysis
- Abbott Laboratories - Astra Zeneca - Julphar - Kuwait Saudi Pharmaceutical Industries Company - Novocol - Pharma Solutions Industries - Riyadh Pharma - Septodont
For more information visit
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets